GKWIM
VBIV

Gerber Kawasaki Wealth & Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33
Closed -$3K – 1180
2021
Q3 		$3K Buy
+33
New +$3.13K ﹤0.01% 866

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's VBIV Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2021, closing a stake of 33 shares — an estimated $3K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in VBIV in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 33 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2021, an estimated $3K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $3K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.